HomeCompareCHME vs DIVO

CHME vs DIVO: Dividend Comparison 2026

CHME yields 19801.98% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHME wins by $1130405.64M in total portfolio value
10 years
CHME
CHME
● Live price
19801.98%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1130405.67M
Annual income
$101,177,204,557.67
Full CHME calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — CHME vs DIVO

📍 CHME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHMEDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHME + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHME pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHME
Annual income on $10K today (after 15% tax)
$1,683,168.32/yr
After 10yr DRIP, annual income (after tax)
$86,000,623,874.02/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, CHME beats the other by $86,000,623,039.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHME + DIVO for your $10,000?

CHME: 50%DIVO: 50%
100% DIVO50/50100% CHME
Portfolio after 10yr
$565202.85M
Annual income
$50,588,602,769.67/yr
Blended yield
8.95%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHME buys
0
DIVO buys
0
No recent congressional trades found for CHME or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHMEDIVO
Forward yield19801.98%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$1130405.67M$30.7K
Annual income after 10y$101,177,204,557.67$981.68
Total dividends collected$955841.06M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CHME vs DIVO ($10,000, DRIP)

YearCHME PortfolioCHME Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$1,000,799$990,099.01$11,349$649.42+$989.5KCHME
2$47,374,131$46,303,276.11$12,833$688.83+$47.36MCHME
3$1,074,908,161$1,024,217,841.10$14,459$727.90+$1074.89MCHME
4$12,009,622,648$10,859,470,915.11$16,238$766.49+$12009.61MCHME
5$69,546,358,216$56,696,061,982.96$18,179$804.47+$69546.34MCHME
6$227,835,371,365$153,420,768,073.78$20,293$841.71+$227835.35MCHME
7$478,648,216,202$234,864,368,841.84$22,591$878.14+$478648.19MCHME
8$742,721,392,306$230,567,800,969.61$25,087$913.65+$742721.37MCHME
9$961,895,759,073$167,183,869,305.91$27,791$948.18+$961895.73MCHME
10$1,130,405,666,766$101,177,204,557.67$30,718$981.68+$1130405.64MCHME

CHME vs DIVO: Complete Analysis 2026

CHMEStock

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Full CHME Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this CHME vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHME vs SCHDCHME vs JEPICHME vs OCHME vs KOCHME vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.